SUSTAINED RELEASE COMPOSITIONS OF RANOLAZINE The present invention relates to pharmaceutical compositions of Ranolazine or pharmaceutically acceptable salts, polymorphs, solvates, hydrates, enantiomers thereof. In particular the present invention relates to sustained release dosage forms of Ranolazine comprising a combination of pH-independent binders and acids, and optionally one or more pharmaceutically acceptable excipients.